Gelain, Daniel Pens

Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment

Gasparotto, J., Girardi, C. S., Somensi, N., Ribeiro, C. T., Moreira, J. C. F., Michels, M., Sonai, B., Rocha, M., Steckert, A. V., Barichello, T., et al. (2018) · Journal of Biological Chemistry

Advanced Glycation End Products researchAlzheimer's disease research and treatments

Cited by 120

NFκB inhibitors induce cell death in glioblastomas

Zanotto-Filho, A., Braganhol, E., Schröder, R., de Souza, L. H. T., Dalmolin, R. J. S., Pasquali, M. A. B., Gelain, D. P., Battastini, A. M. O., & Moreira, J. C. F. (2011) · Biochemical Pharmacology

Glioma Diagnosis and TreatmentNF-κB Signaling Pathways

Cited by 117

Systemic Inflammation Changes the Site of RAGE Expression from Endothelial Cells to Neurons in Different Brain Areas

Gasparotto, J., Ribeiro, C. T., da Rosa-Silva, H. T., Bortolin, R. C., Rabelo, T. K., Peixoto, D. O., Moreira, J. C. F., & Gelain, D. P. (2019) · Molecular Neurobiology

Advanced Glycation End Products researchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 36

LDL Receptor Deficiency Does not Alter Brain Amyloid-β Levels but Causes an Exacerbation of Apoptosis

de Oliveira, J., Engel, D. F., de Paula, G. C., Melo, H. M., Lopes, S. C., Ribeiro, C. T., Delanogare, E., Moreira, J. C. F., Gelain, D. P., Prediger, R. D., et al. (2020) · Journal of Alzheimer’s Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 31

Estimating the replicability of Brazilian biomedical science

Initiative, T. B. R., Amaral, O. B., Carneiro, C. F. D., Neves, K., Sampaio, A. P. W., Gomes, B. V., Abreu, M. B. D., Tan, P. B., Mota, G. P. S., Goulart, R. N., et al. (2025) · bioRxiv

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 13